Therapeutics: Peroxisome proliferation activated receptor γ (PPARγ)

Mouse studies suggest nanoparticles loaded with the generic PPARγ activator rosiglitazone and targeted to adipose tissue vasculature could help treat obesity. The nanoparticles consisted of a poly(lac...